Background {#Sec1}
==========

Total knee arthroplasty (TKA) has been one of the most successful operations for patients with end-stage knee diseases. As the standard approach, the medial parapatellar approach has been popularized for the excellent operative visualization. However, this approach requires the compromise of peripatellar blood supply and the quadriceps muscle, which might cause avascular necrosis and anterior knee pain \[[@CR1]\].

In the last decade, the minimally invasive approaches such as mini-medial parapatellar, midvastus, subvastus and quadriceps-sparing approach, have provided promising advantages over the standard approach. The mini-medial parapatellar and midvastus approaches were less minimally invasive than the standard approach, but both disrupted quadriceps mechanism during surgery \[[@CR2]--[@CR4]\]. Compared with the above two approaches, the quadriceps-sparing and subvastus approaches were regarded as truly "anatomic" techniques in TKA because both avoided the disruption of the quadriceps tendon and the insertion of the vastus medialis in TKA \[[@CR5]--[@CR7]\]. Therefore, these two techniques also were described as the least minimally invasive approaches for TKA \[[@CR8]--[@CR10]\].

Theoretically, the quadriceps-sparing and subvastus approaches could offer better clinical outcomes for patients \[[@CR11]--[@CR15]\]. Previously, many studies have compared the clinical outcomes between the quadriceps-sparing or subvastus approach with the standard parapatellar approach. However, their conclusions among studies still remain conflicting. Some studies advocated the use of subvastus or quadriceps-sparing approach. They reported that these two approaches had significant advantages in knee society scores (KSS) \[[@CR1], [@CR16], [@CR17]\], straight-leg raise \[[@CR17]--[@CR19]\], visual analogue score (VAS) \[[@CR17]\] and range of motion (ROM) \[[@CR16], [@CR18], [@CR20], [@CR21]\]. However, other studies did not support this viewpoint. They found that the standard parapatellar approach provided less complications and better knee function than the subvastus or the quadriceps-sparing approaches \[[@CR14], [@CR19], [@CR22]--[@CR26]\].

To quantitatively compare the clinical efficacy and safety of the quadriceps-sparing and subvastus approaches to the standard parapatellar approach in TKA, we included all the published randomized controlled trials (RCTs) and conducted this meta-analysis.

Methods {#Sec2}
=======

This meta-analysis was performed in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines \[[@CR27]\].

Inclusion criteria {#Sec3}
------------------

The studies were included if they were randomized controlled trials (RCTs) comparing the subvastus or quadriceps-sparing approach with the standard parapatellar approach in TKA. Case report, cohort study, quasi-RCT and non-RCT were excluded in this study not considered for inclusion. The included participants should be adult patients who underwent the primary TKA. The extracted outcomes included: KSS and VAS, ROM, lateral retinacular release, straight leg raise, blood loss, operative time, hospital stay and postoperative complications (wound infection, deep vein thrombosis and total complications).

Literature search {#Sec4}
-----------------

The databases of PubMed, the Cochrane library, EMBASE, Chinese Biomedical Database and ISI Web of Knowledge were searched for the relevant studies from January 1982 to July 2014. The following search strategies were used for literature search: \#1, "Arthroplasty, Replacement, Knee" \[Mesh\]; \#2, knee arthroplasty; \#3. knee replacement, \#4. medial parapatellar; \#5. standard OR conventional approach; \# 6. subvastus; \#7. mini-subvastus; \#8. quadriceps-sparing; \#9. quad-sparing; \#10. quadriceps sparing; \#11. \#1 OR \#2 OR \# 3 OR; \# 12. \#4 OR \# 5; \# 13. \#6 OR \#7 OR \#8 OR \# 9 OR \#10; \# 11 AND \# 12 AND \# 13. In addition, the lists of references and Google scholar were also searched for other potential RCTs.

Data collection and quality assessment {#Sec5}
--------------------------------------

Two authors independently screened the titles and abstracts. If the studies possibly met the inclusion criteria, the full text was retrieved for the final decision. Data extraction was completed by two blind authors. If insufficient data was reported, efforts were made to contact the authors for the additional information. The methodological quality was evaluated using the following items recommended by the Cochrane Collaboration \[[@CR28]\]: randomization; allocation concealment; blinding of participants; blinding of outcome assessors; incomplete outcome data; selective reporting; and other bias. Each item was classified into "Yes", "No", or "Unclear": "Yes" - low risk of bias, "No" - high risk of bias, "Unclear" - lack of information or unknown risk of bias. Any disagreement in assessments was resolved by discussing with a third author.

Statistical analysis {#Sec6}
--------------------

The software of Review Manager 5.2.7 \[[@CR28]\] was used to perform meta-analysis. Odds ratios (OR) and 95 % confidence interval (95 % CI) was calculated to test the overall effects for dichotomous outcomes, and mean difference (MD) and 95 % CI were used for continuous outcomes. Heterogeneity was tested using *I*^*2*^ statistic (*I*^*2*^ \> 50 % indicating significant heterogeneity, and *I*^*2*^ ≤ 50 % indicating no significant heterogeneity) \[[@CR29]\]. If significant heterogeneity (*I*^*2*^ \> 50 %) was found in the meta-analysis, random-effect model was used, otherwise, using fix-effect model. Subgroup analysis was performed for outcomes with different time points.

Results {#Sec7}
=======

Figure [1](#Fig1){ref-type="fig"} showed the flow chart of literature screening. From the initial database search, a total of 423 citations were yielded. After removing 165 duplicates, 258 studies were reserved for abstract screening and full-text screening. Finally, nineteen RCTs \[[@CR12], [@CR14], [@CR16], [@CR18]--[@CR26], [@CR30]--[@CR36]\] were considered to be eligible for meta-analysis. Of the included studies, nine \[[@CR14], [@CR17], [@CR19], [@CR22], [@CR31]--[@CR35]\] RCTs comparing the quadriceps-sparing approach with the standard parapatellar approach and ten \[[@CR12], [@CR16], [@CR18], [@CR20], [@CR21], [@CR23]--[@CR26], [@CR30]\] comparing the subvastus approach with the standard parapatellar approach were included.Fig. 1Flow chart of literature screening

The characteristics and quality assessment of the included RCTs {#Sec8}
---------------------------------------------------------------

The characteristics of the included RCTs were summarized in Table [1](#Tab1){ref-type="table"}. A total of 1633 TKAs were performed in 1578 adult patients (male: 31.8 %; female: 68.2 %). The mean age ranged from 62.5--73.8, the mean BMI ranged from 24.6--30.97, and the follow-up duration ranged from 13 days to 3 years. The patients' parameters (age, BMI, patient/TKA number, preoperative knee function) were reported similar between groups.Table 1Characteristics of included studiesStudy-yearCountryGroupPatients (male/female)Total TKAAgeBMIFollow-upResults favoringChiang 2012ChinaQS30 (3/27)3869.7 ± 5.328.6 ± 3.82 yearsMPSP30 (3/27)3769.8 ± 5.429.6 ± 3.5Karpman 2009AmericaQS20 (8/12)2073 ± 7.428 ± 4.46 monthsQSSP19 (9/10)1973 ± 5.129 ± 4.6Kim 2007KoreaQS120 (27/93)12065.4 (43--88)28.1 (19--36)2 yearsMPSP120 (27/93)120Lin 2009ChinaQS30 (3/27)4069.6 (57--78)28.1 (20.1--36.9)2 monthN.SSP30 (3/27)4070.2 (56--82)29.0 (20.1--36.9)Lin 2013ChinaQS35 (5/30)3567.7 ± 526.3 ± 2.52 yearsQSSP35 (5/30)3568.5 ± 5.525.9 ± 2.6Matsumoto 2011JapanQS25 (0/25)2573.8 ± 1.7Not reported1 weekQSSP25 (0/25)2573.7 ± 1.4Not reportedShen 2007ChinaQS26 (−/−)26Not reportedNot reported12 yearsQSSP33 (−/−)33Not reportedNot reportedTasker 2013United KingdomQS46 (17/29)4667.3 ± 8.4Not reported2 yearsQSSP46 (17/29)4668.2 ± 7.5Not reportedXu 2013ChinaQS26 (7/19)3563.5 ± 8.725.2 ± 3.43 monthsQSSP29 (11/18)3564.2 ± 9.325.2 ± 2.3Roysam 2001United KingdomSV46 (25/21)4670.2Not reported3 monthsSVSP43 (22/21)4369.8Not reportedWeinhardt 2004GermanSV26 (19/7)2669.7 ± 9.1Not reported13 daysN.SSP26 (14/12)2673.7 ± 6.8Not reportedBridgman 2009United KingdomSV116 (60/56)11670.1 ± 8.0Not reported1 yearSVSP115 (59/56)11570.9 ± 8.1Not reportedSastre 2009SpainSV56 (not reported)56NRNot reported1 yearSVSP48 (not reported)48Not reportedNot reportedPan 2010ChinaSV35 (11/24)3562.5 (54--70)24.8 (19.5--28.6)18 monthsN.SSP33 (9/24)3363.2 (50--75)24.6 (19.4--28.2)Varela-EgocheagaSpainSV50 (14/36)5068.02 ± 8.1430.97 ± 5.253 yearsSVSP50 (13/37)5070.64 ± 7.8830.62 ± 3.42Van Hemert 2010NetherlandsSV20 (6/14)2070.3 ± 11.829.2 ± 5.53 monthsN.SSP20 (7/13)2070.9 ± 7.130.3 ± 5.9Varnell 2011ItalySV18 (11/7)2071 ± 630.96 ± 6.166 monthsMPSP15 (5/10)1870 ± 728.15 ± 4.2Wegrzyn 2013USASV18 (4/14)1871 ± 630.96 ± 6.162 monthsN.SSP18 (4/14)1870 ± 728.15 ± 4.2Jain 2013IndiaSV50 (12/38)5067 ± 830 ± 62 weeksSVSP50 (12/38)5064 ± 731 ± 4*BMI* body mass index, *SV* subvastus, *SP* standard parapatellar, *QS* quadriceps-sparing, *N.S* not significant

Regarding the methodological quality, all the included studies were randomized using various methods: eight (42.1 %) used the computer-generated random number and seven (36.8 %) used random number table. Allocation concealment was reported in 10 studies (52.6 %); the method of blind was used in 16 studies (84.2 %) (Table [2](#Tab2){ref-type="table"}).Table 2Risk of bias in included studiesStudyRandom Sequence GenerationAllocation concealmentBlinding of participantsBlinding of outcome assessmentIncomplete Outcome dataSelective reportingOther biasKim 2007Yes (Randomization table)UnclearUnclearYesYesUnclearUnclearShen 2007Yes (Not reported)UnclearUnclearUnclearYesUnclearUnclearKarpman 2009Yes (Computer)UnclearYesYesYesUnclearUnclearLin 2009Yes (Computer)Yes (Sealed envelope)YesYesYesUnclearUnclearMatsumoto 2011Yes (Not reported)UnclearYesUnclearYesUnclearUnclearChiang 2012Yes (computer)UnclearYesYesYesYesUnclearLin 2013Yes (Randomization table)Yes (Sealed envelope)UnclearYesYesUnclearUnclearTasker 2013Yes (Randomization table)Yes (Sealed envelope)YesYesYesUnclearUnclearXu 2013Yes (Randomization table)Yes (Sealed envelope)UnclearUnclearYesUnclearUnclearRoysam 2001Yes (Random number table)Yes (Sealed envelope)YesYesYesUnclearUnclearWeinhardt 2004Yes (Not reported)UnclearUnclearUnclearYesUnclearUnclearBridgman 2009Yes (Computer)Yes (Telephone)YesYesYesYESUnclearSastre 2009Yes (Random number table)Yes (Sealed envelope)YesYesNoUnclearUnclearPan 2010Yes (Computer)Yes (Sealed envelope)YesNoYesUnclearUnclearVarela-Egocheaga 2010Yes (Random number table)UnclearUnclearUnclearYesUnclearUnclearVan Hemert 2010Yes (Not reported)UnclearYesYesYesUnclearUnclearBourke 2012Yes (Computer)Yes (Sealed envelope)YesYesNoUnclearUnclearWegrzyn 2013Yes (Computer)UnclearYesYesYesUnclearUnclearJain 2013Yes (Computer)Yes (Block schedule)YesUnclearYesUnclearUnclear

Results of meta-analysis {#Sec9}
------------------------

### Quadriceps-sparing versus the standard parapatellar approach {#Sec10}

Nine RCTs \[[@CR14], [@CR17], [@CR19], [@CR22], [@CR31]--[@CR35]\] comparing the quadriceps-sparing with the standard parapatellar approaches were included for meta-analysis (*n* = 725 patients with 775 TKAs) (Table [3](#Tab3){ref-type="table"}).Table 3Meta-analysis of quadriceps-sparing (QS) versus standard parapatellar (SP) approachOutcomesStudiesNo. of TKAs (QS/SP)MD or OR (95 % CI); *p* valueHeterogeneityKSS 4--6 weeks3101108−0.91 \[−3.08, 1.25\]; *p* = 0.41*I* ^*2*^ = 0 %KSS 3 months21381382.88 \[1.17, 4.60\]; *p* = 0.001*I* ^*2*^ = 0 %KSS 2 year21551551.75 \[0.45, 3.06\]; *p* = 0.008*I* ^*2*^ = 0 %VAS 1 weeks4124129−0.69 \[−1.10, −0.29\]; *p* \< 0.05*I* ^*2*^ = 32 %VAS 4--6 weeks31041100.14 \[−0.29, 0.58\]; *p* = 0.52*I* ^*2*^ = 0 %Total Complication62792871.00 \[0.21, 4.72\]; *p* = 0.49*I* ^*2*^ = 0 %Wound infection62792871.05 \[0.39, 2.85\]; *p* = 0.85*I* ^*2*^ = 0 %Deep vein thrombosis62792870.67 \[0.16, 2.92\]; *p* = 0.30*I* ^*2*^ = 0 %ROM 1 week264705.79 \[−6.26, 17.85\]; *p* = 0.35*I* ^*2*^ = 89 %ROM 4--6 weeks3991053.83 \[−2.81, 10.46\]; *p* = 0.26*I* ^*2*^ = 84 %ROM 3 months21461534.37 \[−6.41, 15.14\]; *p* = 0.43*I* ^*2*^ = 96 %ROM 12 months2667610.08 \[−7.56, 27.72\]; *p* = 0.26*I* ^*2*^ = 96 %ROM 24 months4233235−0.18 \[−1.91, 1.56\]; *p* = 0.84*I* ^*2*^ = 0 %Operative time731932718.22 \[9.92, 26.51\]; *p* \< 0.05*I* ^*2*^ = 93 %Blood loss42202220.80 \[−39.34, 40.93\]; *p* = 0.97*I* ^*2*^ = 0 %Hospital stay4215217−0.68 \[−1.48, 0.12\]; *p* = 0.10*I* ^*2*^ = 82 %

Primary outcomes {#Sec11}
----------------

Meta-analysis showed that, when compared with the standard approach, the quadriceps-sparing approach significantly improved KSS at postoperative 3 months (MD = 2.88, 95 % CI \[1.17, 4.60\], *P* = 0.001) and 2 years (MD = 1.75, 95 % CI \[0.45, 3.06\], *p* = 0.08), and decreased VAS at postoperative 1 week (MD = −0.69, 95 % CI \[−1.10, −0.29\], *P* \< 0.05). There were no differences in KSS at postoperative 4--6 weeks (MD = −0.91, 95 % CI \[−3.08, 1.25\], *P* = 0.41) and VAS at postoperative 4--6 weeks (MD = 0.14, 95 % CI \[−0.29, 0.58\], *P* = 0.52) between both groups. No significant heterogeneity was found in the meta-analysis of KSS and VAS (*I*^*2*^ ≤ 50 %) (Table [3](#Tab3){ref-type="table"}).

Secondary outcomes {#Sec12}
------------------

Meta-analysis showed that the quadriceps-sparing and the standard parapatellar approaches had similar results in total complication (MD = 1.00, 95 % CI \[0.21, 4.72\], *P* = 0.49), wound infection (MD = 1.21, 95 % CI \[0.29, 5.05\], *P* = 0.80), deep vein thrombosis (MD = 0.65, 95 % CI \[0.13, 3.31\], *P* = 0.60), ROM from 1 week (MD = 5.79, 95 % CI \[−6.26, 17.85\], *P* = 0.35 %)--24 months (MD = −0.18, 95 % CI \[−1.91, 1.56\], *P* = 0.84), blood loss (MD = −57.00, 95 % CI \[−213.73, 99.73\]) and hospital stay (MD = −2.00, 95 % CI \[−3.19, −0.81\], *P* = 0.10). However, the quadriceps-sparing approach significantly increased operative time when compared with the standard parapatellar approach (MD = 18.22, 95 % CI \[9.92, 26.51\], *P* \< 0.05). The heterogeneity was significant in ROM, operative time and hospital stay (*I*^*2*^ \> 50 %) (Table [3](#Tab3){ref-type="table"}).

Subvastus versus Medial parapatellar approach {#Sec13}
---------------------------------------------

Ten RCTs \[[@CR12], [@CR16], [@CR18], [@CR20], [@CR21], [@CR23]--[@CR26], [@CR30]\] comparing the subvastus with the standard parapatellar approach were included for meta-analysis (Table [4](#Tab4){ref-type="table"}).Table 4Meta-analysis of subvastus (SV) versus standard parapatellar (SP) approachOutcomesStudiesTKAs (SV/SP)MD or OR \[95 % CI\]; *p* valueHeterogeneityKSS 4--6 weeks2128127−1.86 \[−8.59, 4.88\]; *p* = 0.59*I* ^*2*^ = 66 %KSS 3 months41961951.03 \[−10.28, 12.35\]; *p* = 0.86*I* ^*2*^ = 0 %KSS 12 months21611573.25 \[−0.60, 7.10\]; *p* = 0.10*I* ^*2*^ = 0 %VAS 1 weeks2132133−0.56 \[−1.42, 0.29\]; *p* = 0.19*I* ^*2*^ = 98 %VAS 4--6 weeks3182175−0.13 \[−0.44, 0.19\]; *p* = 0.44*I* ^*2*^ = 85 %VAS 3 months3182177−0.03 \[−0.32, 0.27\]; *p* = 0.87*I* ^*2*^ = 84 %VAS 6 months2165159−0.14 \[−0.28, −0.01\]; *p* = 0.04*I* ^*2*^ = 0 %Total Complication63293150.81 \[0.44, 1.49\]; *p* = 0.49*I* ^*2*^ = 0 %Wound infection62422331.11 \[0.40, 3.08\]; *p* = 0.85*I* ^*2*^ = 0 %Deep vein thrombosis52882765.04 \[0.24, 106.22\]; *p* = 0.30*I* ^*2*^ = 0 %ROM 1 week31631663.96 \[3.20, 4.72\]; *p* \< 0.05*I* ^*2*^ = 0 %ROM 4--6 weeks42302253.79 \[−0.44, 8.03\]; *p* = 0.08*I* ^*2*^ = 68 %ROM 3 months42302253.24 \[−0.90, 7.38\]; *p* = 0.12*I* ^*2*^ = 72 %ROM 12 months32142066.80 \[0.94, 12.66\]; *p* = 0.02*I* ^*2*^ = 87 %Straight leg raise25961−2.77 \[−4.07, −1.47\]; *p* \< 0.05*I* ^*2*^ = 64 %Operative time246460.11 \[−10.37, 10.58\]; *p* = 0.98*I* ^*2*^ = 60 %Lateral retinacular release42172110.34 \[0.14, 0.79\]; *p* = 0.01*I* ^*2*^ = 0 %Blood loss38181−100.76 \[−223.42, 21.89\]; *p* = 0.11*I* ^*2*^ = 74 %

Primary outcomes {#Sec14}
----------------

Meta-analysis showed that the subvastus approach significantly reduced VAS score at postoperative 12 months (MD = −0.14, 95 % CI \[−0.28, −0.01\], *P* = 0.04) compared with the standard approach. There were no differences in KSS from postoperative 4 weeks (MD = −1.86, 95 % CI \[−8.59, 4.88\], *P* = 0.59)--12 months (MD = 3.25, 95 % CI \[−0.60, 7.10\]), and VAS from postoperative 1 week (MD = −0.56, 95 % CI \[−1.42, 0.29\], *P* = 0.19)--3 months (MD = −0.03, 95 % CI \[−0.32, 0.27\], *P* = 0.87) between the standard and subvastus groups (Table [3](#Tab3){ref-type="table"}). Significant heterogeneity was found in KSS (4--6 weeks) and VAS (1 week--3 months) (*I*^*2*^ \> 50 %).

Secondary outcomes {#Sec15}
------------------

Meta-analysis showed that the subvastus approach had significant advantages over the standard parapatellar approach in ROM at postoperative 1 week (MD = 3.96, 95 % CI \[3.20, 4.72\], *P* \< 0.05) and 12 months (MD = 6.80, 95 % CI \[0.94, 12.66\], *P* \< 0.05), straight leg raise (OR = −2.77, 95 % CI \[−4.07, −1.47\], *P* =0.02) and lateral retinacular release (OR = 0.34, 95 % CI \[0.14, 0.79\], *P* = 0.01). The two groups showed similar results in ROM at postoperative 4--6 weeks (MD = 3.79, 95 % CI \[−0.44, 8.03\], P = 0.08) and 3 months (MD = 3.24, 95 % CI \[−0.90, 7.38\], *P* = 0.12), total complication (MD = 0.81, 95 % CI \[0.44, 1.49\], *P* = 0.49), wound infection (MD = 1.11, 95 % CI \[0.40, 3.08\]) and blood loss (MD = −100.76, 95 % CI \[−223.42, 21.89\], *P* = 0.11) (Table [4](#Tab4){ref-type="table"}).

Discussion {#Sec16}
==========

Clinically, the quadriceps-sparing and subvastus approaches are very similar techniques, as both avoid the incision into the quadriceps tendon and the vastus medialis muscle during surgery. The quadriceps-sparing approach was first introduced by Tria et al. \[[@CR7]\] from the minimally invasive unicondylar knee replacement. This technique used a more curvilinear medial incision without quadriceps damage and patella eversion. The advantage of the quadriceps-sparing approach was that, if needed, this technique can easily be extended or converted in the standard parapatellar approach \[[@CR10]\]. However, critics indicated that this approach is not anatomically correct. Pagnano et al. \[[@CR37]\] designed a magnetic resonance study in 200 cadaver specimens, and demonstrated that the vastus medialis obliquus was inserted to the midpole of the patella. Therefore, the quadriceps-sparing approach inevitably damaged the vastus medialis obliquus. The subvastus approach was first developed by Hofmann in 1991 \[[@CR38]\]. It preserved the integrity of the extensor mechanism and minimized the injury to the patellar vascularity. Previous studies considered that the subvastus approach should be the true "quadriceps-sparing" approach in TKA \[[@CR8], [@CR18], [@CR39]\].

For the subject concerning the superior approach for TKA, the conclusion was highly controversial. Among the included RCTs, five studies \[[@CR17], [@CR31], [@CR32], [@CR34], [@CR35]\] favored the quadriceps-sparing approach, five \[[@CR12], [@CR16], [@CR18], [@CR20], [@CR21]\] favored subvastus approach, four \[[@CR14], [@CR22], [@CR30], [@CR33]\] favored medial parapatellar approach, and others \[[@CR19], [@CR23]--[@CR26]\] found no differences between groups. Therefore, we conducted a meta-analysis to quantitatively compare the clinical outcomes between the different approaches.

In our study, the most primary findings were that, the quadriceps-sparing approach had significant advantages in KSS and VAS over the standard approach, but had disadvantages in operative time. The subvastus approach provided better outcomes in VAS, ROM, straight leg raise and lateral retinacular release. There were no differences in other clinical outcomes when compared the quadriceps-sparing approach or subvastus with the standard group.

To date, there was no meta-analysis compared the quadriceps-sparing with the standard parapatellar approach in TKA. Totally, we included nine RCTs for meta-analysis. The results demonstrated that the quadriceps-sparing approach achieved better outcomes in KSS (postoperative 3 months and 2 years) and VAS (postoperative 1 week). This result supported the theory of minimally invasive technique. However, the level of this evidence was relatively weak due to the insufficient number of the included RCTs. In addition, our results also showed that the quadriceps-sparing group significantly increased operative time. The explanation was the quadriceps-sparing approach was technically more demanding. That required considerable efforts to obtain sufficient operative view during surgery \[[@CR10]\].

Regarding the subvastus versus the standard parapatellar approach, ten RCTs were available for meta-analysis. Our meta-analysis showed that the subvastus approach had significant advantages over the standard approach in VAS (postoperative 6 months), ROM (postoperative 1 week and 12 months), straight leg raise and lateral retinacular release, and no disadvantages were found associated with the subvastus approach. Our conclusion was a little different with the published meta-analysis \[[@CR1], [@CR40]\]. Teng et al. \[[@CR1]\] performed a meta-analysis including 8 RCTs and 1 quasi-RCTs, and concluded that the subvastus approach improved KSS score and decreased lateral retinacular release compared with the parapatellar approach. However, they found similar ROM in the two groups. The possible reason is that one quasi-RCT they included might bias the result of the meta-analysis. Additionally, despite surgical difficulty was high for the subvastus approach, the operative time showed no difference between the two groups. Our conclusion was in accordance with earlier studies \[[@CR1], [@CR23], [@CR25], [@CR40], [@CR41]\] who also found no difference in operative time between both groups. The familiar exposure and new specific instrumentation contributed to the learning curve of subvastus technique.

Strengths and Limitations of this study {#Sec17}
---------------------------------------

Two earlier systematic review or meta-analysis \[[@CR1], [@CR40]\] had compared the clinical efficiency between the subvastus and the standard aprraoch in TKA. However, the authors included quasi-RCT, which reduced the level of the evidence. Additionally, the published meta-analysis only investigated the short-term outcomes. The strengthens of this study included that: (1) the results of our meta-analysis were based on RCTs, which provided high-level evidence for clinical practice; (2) our study first reported a meta-analysis comparing the quadriceps-sparing with the standard approach.

Several limitations should be noted in our study. (1). Although some outcomes were reported in the full text, data was not sufficiently provided to perform meta-analysis. (2) Although efforts were made to minimize the heterogeneity by conducting subgroup analysis, for example, using random-effect model and setting strict inclusion criteria, the heterogeneity among the included studies was still significant in several meta-analyses, which might decrease the reliability of the conclusion. Readers should be cautious for the results when heterogeneity existed. (3) Although all the included RCTs used randomization, some RCTs did not used allocation concealment and blinding to the patients and surgeons, which also might lead to high risks of selection and detection bias; besides, the most RCTs included were performed in single center with small samples, therefore, multi-center RCTs with large-samples are still lacking to verify our conclusion. (4) For a superior approach in TKA, it should include the following criteria: simple technique, sufficient visibility, less complication rates and improve clinical outcomes. Obviously, the quadriceps-sparing or subvastus approach did not involve all the criteria above. Therefore, TKA surgeons should get a balanced perspective for the two approaches.

Conclusion {#Sec18}
==========

Based on the current evidence, our study finds that, in comparison with the standard parapatellar approach, the quadriceps-sparing approach showed better outcomes in KSS and VAS, and the subvastus approach shows better outcomes in VAS, ROM, straight leg raise and lateral retinacular release, but the quadriceps-sparing technique requires longer operative time.
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=================

Therapeutic study Level I
